Suppliers / Ampharco

Ampharco

Updated 9 July 2026

Ampharco is an API and finished-dose manufacturer. It appears in 336 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
336
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Hydroclorothiazide DAV (Vietnam) 6
Entecavir DAV (Vietnam) 4
Etoricoxib DAV (Vietnam) 4
Glimepiride DAV (Vietnam) 4
Ursodeoxycholic Acid DAV (Vietnam) 4
Desloratadine DAV (Vietnam) 3
Lisinopril DAV (Vietnam) 3
Sitagliptin DAV (Vietnam) 3
Valsartan DAV (Vietnam) 3
Acid Amin DAV (Vietnam) 2
Show all 30 molecules on file
Adapalene DAV (Vietnam) 2
Carbocisteine DAV (Vietnam) 2
Diosmin DAV (Vietnam) 2
Esomeprazole DAV (Vietnam) 2
Febuxostat DAV (Vietnam) 2
Fexofenadine DAV (Vietnam) 2
Ibuprofen DAV (Vietnam) 2
Lercanidipine DAV (Vietnam) 2
Ondansetron DAV (Vietnam) 2
Racecadotril DAV (Vietnam) 2
Telmisartan DAV (Vietnam) 2
Azithromycin DAV (Vietnam) 1
Cetirizine DAV (Vietnam) 1
Clobetasol Propionate DAV (Vietnam) 1
Clotrimazole DAV (Vietnam) 1
Cobalamin DAV (Vietnam) 1
Gabapentin DAV (Vietnam) 1
Itraconazole DAV (Vietnam) 1
Ketoprofen DAV (Vietnam) 1
Levetiracetam DAV (Vietnam) 1

Also appears on these molecule pages

Show 15 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 336 None

Comparing suppliers?

Choose your molecules and target markets. Ampharco comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability